BIOGEN INC. (BIIB) Share-based Payment Arrangement, Expense USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biogen Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2024.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was -$76.1 M, a 3.55% increase year-over-year.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was -$272 M, a 0.15% increase year-over-year.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$272 M -$76.1 M +$2.8 M +3.55% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 -$274 M -$56.6 M +$12.8 M +18.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q4 2023 -$274 M -$274 M -$10.9 M -4.14% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 -$287 M -$64.8 M +$900 K +1.37% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$288 M -$74.1 M -$16.1 M -27.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-25
Q1 2023 -$272 M -$78.9 M -$8.5 M -12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 -$264 M -$69.4 M -$8.8 M -14.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q4 2022 -$264 M -$264 M -$16.9 M -6.85% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 -$255 M -$65.7 M -$8.1 M -14.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$247 M -$58 M -$2.2 M -3.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 -$244 M -$70.4 M +$2.2 M +3.03% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 -$247 M -$60.6 M -$10.2 M -20.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q4 2021 -$247 M -$247 M -$42.1 M -20.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 -$236 M -$57.6 M -$22.2 M -62.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 -$214 M -$55.8 M -$6.3 M -12.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 -$208 M -$72.6 M -$3.4 M -4.91% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$205 M -$50.4 M +$87 M +63.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q4 2020 -$205 M -$205 M -$13.3 M -6.96% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 -$292 M -$35.4 M +$12.4 M +25.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 -$304 M -$49.5 M +$5.5 M +10% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 -$309 M -$69.2 M -$118 M -241% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 -$191 M -$137 M +$160 M +53.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q4 2019 -$191 M -$191 M -$22.5 M -13.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 -$351 M -$47.8 M -$88.2 M -218% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 -$263 M -$55 M -$96.4 M -233% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 -$166 M $49 M +$2.3 M +4.93% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 -$169 M -$297 M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q4 2018 -$169 M -$169 M -$307 M -222% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $40.4 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $41.4 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $46.7 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $138 M $138 M +$276 M Jan 1, 2017 Dec 31, 2017 10-K 2019-02-06
Q4 2016 -$138 M -$138 M -$321 M -175% Jan 1, 2016 Dec 31, 2016 10-K 2020-02-06
Q4 2015 $183 M $183 M +$18.2 M +11% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q4 2014 $165 M $165 M +$18.8 M +12.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-02
Q4 2013 $146 M $146 M +$22.2 M +17.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-03
Q4 2012 $124 M $124 M +$6.61 M +5.63% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-04
Q4 2011 $117 M $117 M -$54.1 M -31.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-06
Q3 2011 $36.6 M -$6.2 M -14.5% Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $36.1 M -$13.3 M -26.9% Apr 1, 2011 Jun 30, 2011 10-Q 2011-07-26
Q4 2010 $171 M $171 M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-05
Q3 2010 $42.8 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $49.4 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.